MA31988B1 - Derives d'aminopyrazole - Google Patents

Derives d'aminopyrazole

Info

Publication number
MA31988B1
MA31988B1 MA32967A MA32967A MA31988B1 MA 31988 B1 MA31988 B1 MA 31988B1 MA 32967 A MA32967 A MA 32967A MA 32967 A MA32967 A MA 32967A MA 31988 B1 MA31988 B1 MA 31988B1
Authority
MA
Morocco
Prior art keywords
derivatives
aminoprazole
relates
formula
preparation
Prior art date
Application number
MA32967A
Other languages
Arabic (ar)
English (en)
Inventor
Daniel Bur
Olivier Corminboeuf
Sylvaine Cren
Heinz Fretz
Corinna Grisostomi
Xavier Leroy
Julien Pothier
Sylvia Richard-Bildstein
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MA31988B1 publication Critical patent/MA31988B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention porte sur des dérivés d'aminopyrazole représentés par la formule (i), (i) où a, e, r1 et r2 sont tels que définis dans la description. L'invention porte également sur la préparation de ces dérivés et sur leur utilisation comme composés pharmaceutiquement actifs.
MA32967A 2007-12-14 2010-06-29 Derives d'aminopyrazole MA31988B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2007055111 2007-12-14
IB2008053648 2008-09-10
PCT/IB2008/055251 WO2009077954A1 (fr) 2007-12-14 2008-12-12 Dérivés d'aminopyrazole

Publications (1)

Publication Number Publication Date
MA31988B1 true MA31988B1 (fr) 2011-01-03

Family

ID=40456559

Family Applications (1)

Application Number Title Priority Date Filing Date
MA32967A MA31988B1 (fr) 2007-12-14 2010-06-29 Derives d'aminopyrazole

Country Status (24)

Country Link
US (1) US8288419B2 (fr)
EP (1) EP2242743B1 (fr)
JP (1) JP5435744B2 (fr)
KR (1) KR101622413B1 (fr)
CN (1) CN101903353B (fr)
AR (1) AR069650A1 (fr)
BR (1) BRPI0821004A8 (fr)
CA (1) CA2706836C (fr)
CY (1) CY1114793T1 (fr)
DK (1) DK2242743T3 (fr)
ES (1) ES2432059T3 (fr)
HR (1) HRP20131105T1 (fr)
IL (1) IL206296A (fr)
MA (1) MA31988B1 (fr)
MX (1) MX2010005827A (fr)
MY (1) MY153921A (fr)
NZ (1) NZ586776A (fr)
PL (1) PL2242743T3 (fr)
PT (1) PT2242743E (fr)
RU (1) RU2489426C2 (fr)
SI (1) SI2242743T1 (fr)
TW (1) TWI430795B (fr)
WO (1) WO2009077954A1 (fr)
ZA (1) ZA201004939B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0821115A8 (pt) 2007-12-18 2017-12-26 Actelion Pharmaceuticals Ltd Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
JP5510945B2 (ja) 2009-05-18 2014-06-04 アクテリオン ファーマシューティカルズ リミテッド Ａｌｘ受容体及び／又はｆｐｒｌ２アゴニストとしての架橋スピロ［２．４］ヘプタン誘導体
NZ597453A (en) 2009-06-09 2013-03-28 Actelion Pharmaceuticals Ltd Fluorinated aminotriazole derivatives as alxr agonists
CA2760887A1 (fr) 2009-06-12 2010-12-16 Actelion Pharmaceuticals Ltd Derives de l'oxazole et du thiazole en tant qu'agonistes du recepteur alx
CA2794801C (fr) 2010-04-07 2019-01-15 F. Hoffmann-La Roche Ag Composes pyrazol-4-yl-heterocyclyle-carboxamide et leurs procedes d'utilisation
WO2012066488A2 (fr) 2010-11-17 2012-05-24 Actelion Pharmaceuticals Ltd Dérivés à ponts ester de spiro [2.4] heptane
EP2648724B1 (fr) * 2010-12-07 2016-09-21 Actelion Pharmaceuticals Ltd. Dérivés d'aminotriazole hydroxylés convenant comme agonistes du récepteur alx
PL2649068T3 (pl) 2010-12-07 2015-03-31 Idorsia Pharmaceuticals Ltd Pochodne eteru oksazolilowo-metylowego jako agoniści receptora ALX
ES2541531T3 (es) 2011-02-18 2015-07-21 Actelion Pharmaceuticals Ltd. Nuevos derivados de pirazol e imidazol útiles como antagonistas de orexina
BR112013028895A2 (pt) 2011-05-10 2016-08-09 Bayer Ip Gmbh (tio)carbonilamidinas bicíclicas
EP2760857A1 (fr) 2011-09-27 2014-08-06 F.Hoffmann-La Roche Ag Composés de type pyrazol-4-yl-hétérocyclyl-carboxamide et leurs méthodes d'utilisation
DE102011055815A1 (de) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung
EP2850058B1 (fr) 2012-05-16 2016-07-13 Actelion Pharmaceuticals Ltd. Dérivés de 1- (p-tolyl) cyclopropyl substituted bridged spiro [2,4] heptane en tant qu' agonistes du récepteur alx.
MA37618B1 (fr) 2012-05-16 2017-08-31 Actelion Pharmaceuticals Ltd Dérivés pontés fluorés de spiro[2.4]heptane en tant qu'agonistes de récepteur alx
DE102012016908A1 (de) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung
AR096686A1 (es) 2013-06-25 2016-01-27 Actelion Pharmaceuticals Ltd Derivados de espiro[2.4]heptano puenteados sustituidos con difluoroetil-oxazol como agonistas del receptor de alx
BR112016001106A8 (pt) 2013-07-18 2017-12-26 Actelion Pharmaceuticals Ltd Derivados de espiro [2,4] heptano interligados piperazina substituídos como agonistas do receptor de alx
AR097279A1 (es) 2013-08-09 2016-03-02 Actelion Pharmaceuticals Ltd Derivados de benzimidazolil-metil urea como agonistas del receptor de alx
EP3305763B1 (fr) 2013-11-28 2019-07-24 Kyorin Pharmaceutical Co., Ltd. Dérivés d'urée deutérés ou marqués par un isotope ou leurs sels pharmacologiquement acceptables en tant qu'agonistes du récepteur fprl-1
AU2016266190A1 (en) 2015-05-27 2018-01-18 Kyorin Pharmaceutical Co., Ltd. Urea derivative or pharmacologically acceptable salt thereof
WO2016189877A1 (fr) 2015-05-27 2016-12-01 Kyorin Pharmaceutical Co., Ltd. Dérivé d'urée ou sel pharmacologiquement acceptable de ce dernier
WO2019173182A1 (fr) 2018-03-05 2019-09-12 Bristol-Myers Squibb Company Agonistes du récepteur 2 du peptide formylé de phénylpyrrolidinone
KR20210028144A (ko) * 2018-04-06 2021-03-11 블랙 벨트 티엑스 리미티드 Atf6 저해제 및 그의 용도
KR20220087464A (ko) 2019-10-09 2022-06-24 프락시스 바이오테크 엘엘씨 Atf6 조정제 및 그의 용도
WO2023118434A1 (fr) * 2021-12-22 2023-06-29 Globachem Nv Composés amides à action pesticide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531019D0 (en) * 1985-12-17 1986-01-29 Beecham Group Plc Compounds
JPS62234018A (ja) 1986-04-02 1987-10-14 Rooto Seiyaku Kk 糖尿病併発症治療剤
TR200102817T2 (tr) * 1999-03-12 2002-05-21 Boehringer Ingelheim Pharmaceuticals, Inc. Antiinflamatuar ajanlar olarak faydalı bileşikler
KR20030030029A (ko) 2000-09-22 2003-04-16 니혼노야쿠가부시키가이샤 Ｎ-(4-피라졸릴)아미드 유도체 및 농원예용 약제 그리고그 사용방법
MXPA03007864A (es) * 2001-03-02 2003-12-04 Hoffmann La Roche Derivados del acido alcoxicarbonilamino-heteroaril carboxilico como antagonistas ip.
JP2005536187A (ja) 2002-04-03 2005-12-02 バイエル・ヘルスケア・アクチェンゲゼルシャフト Ｎ−ホルミルペプチド受容体様１（ｆｐｒｌ１）に関連する疾患の診断および治療
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
WO2005047899A2 (fr) 2003-11-07 2005-05-26 Acadia Pharmaceuticals Inc. Utilisation d'un recepteur de lipoxine, fprl1, en tant qu'outil d'identification de composes efficaces dans le traitement de douleurs et d'inflammations
GB0508472D0 (en) * 2005-04-26 2005-06-01 Glaxo Group Ltd Compounds
CA2626897A1 (fr) 2005-11-03 2007-05-18 Joshua Close Inhibiteurs de l'histone desacetylase a motifs d'aryle-pyrazolyle
GB0606876D0 (en) * 2006-04-05 2006-05-17 Glaxo Group Ltd Compounds
HUE025137T2 (en) 2007-08-21 2016-01-28 Senomyx Inc Compositions are bitter taste blocking (blocking) compounds
BRPI0821115A8 (pt) 2007-12-18 2017-12-26 Actelion Pharmaceuticals Ltd Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
JP5510945B2 (ja) 2009-05-18 2014-06-04 アクテリオン ファーマシューティカルズ リミテッド Ａｌｘ受容体及び／又はｆｐｒｌ２アゴニストとしての架橋スピロ［２．４］ヘプタン誘導体
NZ597453A (en) 2009-06-09 2013-03-28 Actelion Pharmaceuticals Ltd Fluorinated aminotriazole derivatives as alxr agonists
CA2760887A1 (fr) 2009-06-12 2010-12-16 Actelion Pharmaceuticals Ltd Derives de l'oxazole et du thiazole en tant qu'agonistes du recepteur alx

Also Published As

Publication number Publication date
BRPI0821004A8 (pt) 2017-12-26
BRPI0821004A2 (pt) 2015-06-16
HRP20131105T1 (hr) 2013-12-20
SI2242743T1 (sl) 2013-11-29
CA2706836C (fr) 2016-05-17
JP5435744B2 (ja) 2014-03-05
IL206296A (en) 2015-03-31
RU2489426C2 (ru) 2013-08-10
ES2432059T3 (es) 2013-11-29
NZ586776A (en) 2012-06-29
KR101622413B1 (ko) 2016-05-18
CA2706836A1 (fr) 2009-06-25
MY153921A (en) 2015-04-15
IL206296A0 (en) 2010-12-30
TW200924753A (en) 2009-06-16
PT2242743E (pt) 2013-10-28
AU2008337151A1 (en) 2009-06-25
DK2242743T3 (da) 2013-10-14
JP2011506424A (ja) 2011-03-03
EP2242743A1 (fr) 2010-10-27
MX2010005827A (es) 2010-06-11
EP2242743B1 (fr) 2013-08-21
CN101903353A (zh) 2010-12-01
US20110034516A1 (en) 2011-02-10
TWI430795B (zh) 2014-03-21
US8288419B2 (en) 2012-10-16
HK1148286A1 (en) 2011-09-02
CY1114793T1 (el) 2016-12-14
RU2010128240A (ru) 2012-01-20
ZA201004939B (en) 2012-12-27
AR069650A1 (es) 2010-02-10
KR20100098557A (ko) 2010-09-07
CN101903353B (zh) 2013-04-10
PL2242743T3 (pl) 2014-01-31
WO2009077954A1 (fr) 2009-06-25

Similar Documents

Publication Publication Date Title
MA30717B1 (fr) Derives de pyridin-3-yle en tant qu'agents immunomodulateurs
MA30718B1 (fr) Derives de pyridin-4-yle en tant qu'agents immunomodulateurs.
MA31593B1 (fr) Derives de 2-aza-bicyclo[3.3.0]octane
MA31703B1 (fr) Dérivés pyridiniques utilisés comme modulateurs du récepteur s1p1/edg1
WO2019035863A8 (fr) Activateurs de la pyruvate kinase destinés à être utilisés dans le traitement de troubles hématologiques
MA32231B1 (fr) Composés organiques
MA33420B1 (fr) Dérivés fluorés de l'aminotriazole
MA31142B1 (fr) Derives heteroaryles de pyrrolidinyl et piperdinyl cetones.
MA31000B1 (fr) Derives 2-aza-bicyclo[3.1.0]hexane
MA30821B1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes
MA32173B1 (fr) Derives de pyridin-2-yle utilises comme agents immunomodulateurs
MA37891B1 (fr) Alcoxypyrazoles comme activateurs de guanylate cyclase soluble
MA29909B1 (fr) Derives de pyridazine
MA32468B1 (fr) Derives de thiophene ou de thiazole et leur utilisation comme inhibiteurs de pi3k
MA34819B1 (fr) Dérivés bicyclo[3.2.1]octylamide et leurs utilisations
MA30207B1 (fr) Modulateurs des recepteurs de la progesterone a base d'indole sulfonamide
MA38432A1 (fr) Nouveaux dérivés d'octahydro-pyrrolo [3,4-c]-pyrrole et analogues de ceux-ci servant d'inhibiteurs d'autotaxine
MA32151B1 (fr) Derives de 2-aza-bicyclo[2.2.1]heptane
MX2007004699A (es) Derivados de indol y bencimidazol.
MA30162B1 (fr) Nouveaux derives de pyrrole a cycles fusionnes
MA30291B1 (fr) Derives de l'azolopyridin-3-one en tant qu'inhibiteurs de la lipase endotheliale
MA30991B1 (fr) Utilisation de dérivés du benzamide comme agonistes des récepteurs ep4
MA32104B1 (fr) Dérivés d'oxime en tant qu'inhibiteurs de hsp90
TW200612958A (en) Substituted imidazole derivatives
MA29213B1 (fr) Quinolones a substitution macrolones - amino